119th Congress
H.R. 10628: Biosimilars Access and Affordability Act
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Jake Auchincloss D-MAOriginal
- John Joyce R-PAOriginal
- Nathaniel Moran R-TXOriginal
- Kevin Mullin D-CAOriginal
- Scott Peters D-CAOriginal
- Jimmy Panetta D-CAOriginal
- Linda Sánchez D-CAOriginal
- Rudy Yakym R-INOriginal
- Donald Davis D-NC
Who scored on this bill
- 1Nicholas Langworthy SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Nicholas Langworthy
History
- Introduced in the House by Nicholas Langworthy.
Show the full action history (2 actions)
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.